BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 9052475)

  • 1. Early endocrine therapy versus radical prostatectomy combined with early endocrine therapy for stage D1 prostate cancer.
    Schmeller N; Lubos W
    Br J Urol; 1997 Feb; 79(2):226-34. PubMed ID: 9052475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High failure rate associated with long-term follow-up of neoadjuvant androgen deprivation followed by radical prostatectomy for stage C prostatic cancer.
    Cher ML; Shinohara K; Breslin S; Vapnek J; Carroll PR
    Br J Urol; 1995 Jun; 75(6):771-7. PubMed ID: 7542137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer.
    Messing EM; Manola J; Sarosdy M; Wilding G; Crawford ED; Trump D
    N Engl J Med; 1999 Dec; 341(24):1781-8. PubMed ID: 10588962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease progression and survival in patients with prostate carcinoma and positive lymph nodes after radical retropubic prostatectomy.
    Kroepfl D; Loewen H; Roggenbuck U; Musch M; Klevecka V
    BJU Int; 2006 May; 97(5):985-91. PubMed ID: 16643480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of immediate androgen deprivation adjuvant therapy in patients with lymph node positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy].
    Miyamae K; Kitani K; Miyamoto K; Hamada S; Kawano T; Maehara A; Otsuka Y; Otsuka T; Hamada Y
    Nihon Hinyokika Gakkai Zasshi; 2009 Jul; 100(5):570-5. PubMed ID: 19663244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stage D1 prostate cancer. A nonrandomized comparison of conservative treatment options versus radical prostatectomy.
    Cheng CW; Bergstralh EJ; Zincke H
    Cancer; 1993 Feb; 71(3 Suppl):996-1004. PubMed ID: 7679047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended experience with surgical treatment of stage D1 adenocarcinoma of prostate. Significant influences of immediate adjuvant hormonal treatment (orchiectomy) on outcome.
    Zincke H
    Urology; 1989 May; 33(5 Suppl):27-36. PubMed ID: 2775377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of combined transient androgen deprivation and irradiation following radical prostatectomy for prostatic cancer.
    Eulau SM; Tate DJ; Stamey TA; Bagshaw MA; Hancock SL
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):735-40. PubMed ID: 9652832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Complete radical prostatectomy and positive lymph nodes (stages pT1 to 4, N1 to 3, M0, D1)].
    Feyaerts A; Stainier L; Nollevaux MC; De Groote P; Lorge F; Opsomer R; Wese FX; Cosyns JP; Van Cangh P
    Acta Urol Belg; 1998 Mar; 66(1):1-6. PubMed ID: 9611351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction androgen deprivation therapy before radical prostatectomy for prostate cancer--initial results.
    Abbas F; Kaplan M; Soloway MS
    Br J Urol; 1996 Mar; 77(3):423-8. PubMed ID: 8814850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival and quality of life of patients with stage D1 (T1-3 pN1-2 M0) prostate cancer. Radical prostatectomy plus androgen deprivation versus androgen deprivation alone.
    Frohmüller HG; Theiss M; Manseck A; Wirth MP
    Eur Urol; 1995; 27(3):202-6. PubMed ID: 7601183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term results of adjuvant hormonal therapy plus radiotherapy following radical prostatectomy for patients with pT3N0 or pT3N1 prostate cancer.
    Miyake H; Sakai I; Harada K; Hara I; Eto H
    Int J Urol; 2004 Jun; 11(6):397-401. PubMed ID: 15157209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radical retropubic prostatectomy plus orchiectomy versus orchiectomy alone for pTxN+ prostate cancer: a matched comparison.
    Ghavamian R; Bergstralh EJ; Blute ML; Slezak J; Zincke H
    J Urol; 1999 Apr; 161(4):1223-7; discussion 1227-8. PubMed ID: 10081874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy.
    Messing EM; Manola J; Yao J; Kiernan M; Crawford D; Wilding G; di'SantAgnese PA; Trump D;
    Lancet Oncol; 2006 Jun; 7(6):472-9. PubMed ID: 16750497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilateral pelvic lymphadenectomy and radical prostatectomy for clinical stage C prostatic cancer: role of adjuvant treatment for residual cancer and in disease progression.
    Zincke H; Utz DC; Taylor WF
    J Urol; 1986 Jun; 135(6):1199-205. PubMed ID: 3086572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of radiotherapy on node-positive prostate cancer treated with androgen ablation.
    Sands ME; Pollack A; Zagars GK
    Int J Radiat Oncol Biol Phys; 1995 Jan; 31(1):13-9. PubMed ID: 7527796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stage D1 (T1-3, N1-3, M0) prostate cancer: a case-controlled comparison of conservative treatment versus radical prostatectomy.
    Cadeddu JA; Partin AW; Epstein JI; Walsh PC
    Urology; 1997 Aug; 50(2):251-5. PubMed ID: 9255297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen deprivation prior to radical prostatectomy for T2b and T3 prostate cancer.
    Soloway MS; Hachiya T; Civantos F; Murphy WM; Gomez CC; Ruiz HE
    Urology; 1994 Feb; 43(2 Suppl):52-6. PubMed ID: 7509535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome in patients with pTxN+ adenocarcinoma of prostate treated with radical prostatectomy and early androgen ablation.
    Seay TM; Blute ML; Zincke H
    J Urol; 1998 Feb; 159(2):357-64. PubMed ID: 9649239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Radical Prostatectomy on Long-Term Oncologic Outcomes in a Matched Cohort of Men with Pathological Node Positive Prostate Cancer Managed by Castration.
    Bhindi B; Rangel LJ; Mason RJ; Gettman MT; Frank I; Kwon ED; Tollefson MK; Thompson RH; Boorjian SA; Karnes RJ
    J Urol; 2017 Jul; 198(1):86-91. PubMed ID: 28130104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.